policy
Approval and availability of antimicrobials for use in food-producing animals
The availability and effectiveness of antimicrobials, including medically important antimicrobials, are important to support the health and welfare of…
policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.
policy
Sale of human-label drug products to veterinarians
Because there are a limited number of drugs labeled for use in animals, veterinarians need to have access to human-labeled prescription drugs to…
policy
AAAP guidelines for judicious therapeutic use of antimicrobials in poultry
The AVMA has endorsed these guidelines on judicious therapeutic antimicrobial use in poultry production, developed by the American Association of…
policy
Veterinary compounding
Compounding is the customized manipulation of a drug by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs…
policy
Funding of the New Animal Drug Application (NADA) and Abbreviated New Animal Drug Application (ANADA) approval process
To help ensure adequate availability of veterinary drugs, the AVMA supports increased funding of the FDA Center for Veterinary Medicine for the NADA…
policy
AASV basic guidelines of judicious therapeutic use of antimicrobials in swine
The American Association of Swine Veterinarians and AVMA both support these guidelines on judicious therapeutic antimicrobial use in pork production.
JAVMA news
No ruling coming in compounding dispute
A Florida pharmacy and federal drug authorities have fought for 2 1/2 years over the legality of compounding animal drugs from bulk pharmaceutical…
JAVMA news
USAHA wants more work on federal programs, rules
USAHA asks federal authorities to invest more to guard against livestock diseases and let veterinarians transport and use controlled
JAVMA news
Old, new deputy CEO see AVMA moving profession forward
What kept Dr. Elizabeth A. Curry-Galvin on the staff of the AVMA for two decades?
JAVMA news
Q&A with Dr. Elizabeth A. Curry-Galvin
Dr. Elizabeth A. Curry-Galvin, outgoing deputy chief executive officer of the AVMA, answers questions from JAVMA News.
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
JAVMA news
AVMA advocates against prescription mandate bill
In April, AVMA Board of Directors chair Dr. John de Jong testified before a House subcommittee about the Fairness to Pet Owners Act (HR 3174/S 1200),
JAVMA news
The slow rise of generic animal drugs
In human medicine, generic drugs accounted for 88 percent of prescriptions dispensed in the United States as of 2014.